AI assistant
STRATA Skin Sciences, Inc. — Director's Dealing 2016
Mar 14, 2016
35146_dirs_2016-03-14_284f9e68-58bc-468b-8a6f-8801e13e4785.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: STRATA Skin Sciences, Inc. (SSKN)
CIK: 0001051514
Period of Report: 2016-03-10
Reporting Person: Broadfin Healthcare Master Fund Ltd (10% Owner)
Reporting Person: Broadfin Capital, LLC (10% Owner)
Reporting Person: KOTLER KEVIN (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-03-10 | Common Stock | S | 1500 | $1.51 | Disposed | 1272797 | Direct |
| 2016-03-10 | Common Stock | S | 23500 | $1.50 | Disposed | 1249297 | Direct |
| 2016-03-10 | Common Stock | S | 25000 | $1.50 | Disposed | 1224297 | Direct |
| 2016-03-11 | Common Stock | S | 16000 | $1.05 | Disposed | 1208297 | Direct |
| 2016-03-11 | Common Stock | S | 200000 | $1.28 | Disposed | 1008297 | Direct |
Footnotes
F1: The Common Stock is held in the account of Broadfin Healthcare Master Fund, Ltd., a private investment fund managed by Broadfin Capital, LLC and may be deemed to be beneficially owned by Kevin Kotler, managing member of Broadfin Capital, LLC. Each of Broadfin Capital, LLC, Broadfin Healthcare Master Fund, Ltd. and Kevin Kotler disclaim beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and affirmatively disclaim being a "group" for purposes of Section 16 of the Securities Exchange Act of 1934, as amended.